AAAAAA

   
Results: 1-9 |
Results: 9
A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women
Authors: Baron, AT Lafkyk, JM Suman, VJ Hillman, DW Buenafe, MC Boardman, CH Podratz, KC Perez, EA Maihle, NJ
Citation: At. Baron et al., A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women, CANC EPID B, 10(11), 2001, pp. 1175-1185
Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms
Authors: Reiter, JL Threadgill, DW Eley, GD Strunk, KE Danielsen, AJ Sinclair, CS Pearsall, RS Green, PJ Yee, D Lampland, AL Balasubramaniam, S Crossley, TD Magnuson, TR James, CD Maihle, NJ
Citation: Jl. Reiter et al., Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms, GENOMICS, 71(1), 2001, pp. 1-20
Activation of Rho is required for ligand-independent oncogenic signaling by a mutant epidermal growth factor receptor
Authors: Boerner, JL Danielsen, A McManus, MJ Maihle, NJ
Citation: Jl. Boerner et al., Activation of Rho is required for ligand-independent oncogenic signaling by a mutant epidermal growth factor receptor, J BIOL CHEM, 276(5), 2001, pp. 3691-3695
A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4
Authors: Lee, H Akita, RW Sliwkowski, MX Maihle, NJ
Citation: H. Lee et al., A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4, CANCER RES, 61(11), 2001, pp. 4467-4473
Ras-independent oncogenic transformation by an EGF-receptor mutant
Authors: Boerner, JL McManus, MJ Martin, GS Maihle, NJ
Citation: Jl. Boerner et al., Ras-independent oncogenic transformation by an EGF-receptor mutant, J CELL SCI, 113(6), 2000, pp. 935-942
An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex
Authors: McManus, MJ Boerner, JL Danielsen, AJ Wang, Z Matsumura, F Maihle, NJ
Citation: Mj. Mcmanus et al., An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex, J BIOL CHEM, 275(45), 2000, pp. 35328-35334
Correspondence re: S. Shintani et al., intragenic mutation analysis of thehuman epidermal growth factor receptor (EGFR) gene in malignant human oralkeratinocytes. Cancer Res., 59 : 4142-4147, 1999.
Authors: Reiter, JL Eley, G James, CD Maihle, NJ
Citation: Jl. Reiter et al., Correspondence re: S. Shintani et al., intragenic mutation analysis of thehuman epidermal growth factor receptor (EGFR) gene in malignant human oralkeratinocytes. Cancer Res., 59 : 4142-4147, 1999., CANCER RES, 60(3), 2000, pp. 766-766
Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer
Authors: Baron, AT Lafky, JM Boardman, CH Balasubramaniam, S Suman, VJ Podratz, KC Maihle, NJ
Citation: At. Baron et al., Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer, CANC EPID B, 8(2), 1999, pp. 129-137
Tyrosine phosphorylation of caldesmon is required for binding to the Shc center dot Grb2 complex
Authors: Wang, Z Danielsen, AJ Maihle, NJ McManus, MJ
Citation: Z. Wang et al., Tyrosine phosphorylation of caldesmon is required for binding to the Shc center dot Grb2 complex, J BIOL CHEM, 274(47), 1999, pp. 33807-33813
Risultati: 1-9 |